NEW DELHI, India — Gland Pharma shares climbed sharply on Tuesday, August 11, hitting a fresh 52-week high after the drugmaker reported a strong first-quarter performance for FY27. The stock rose as much as 12% in early trading, with investors assessing whether stronger US sales, improving profitability and new contract opportunities could ease some of the company’s earlier growth challenges.